Association between serum levels of glial cell line-derived neurotrophic factor and inattention in adult patients with attention deficits/hyperactivity disorder

Psychiatry Res. 2021 Feb:296:113674. doi: 10.1016/j.psychres.2020.113674. Epub 2020 Dec 29.

Abstract

Glial cell line-derived neurotrophic factor (GDNF) may play an important role in attention. We investigated the association between serum GDNF levels and clinical status in unmedicated adults with attention deficit/hyperactivity disorder (ADHD) (n = 16) and healthy controls (n = 33); the levels were comparable between the ADHD and control groups (107.2 ± 31.7 vs. 110.5 ± 40.0 pg/mL, respectively; p = 0.77). In the ADHD group, higher GDNF serum levels were associated with severe subjective inattention (r = 0.528, p = 0.035). These preliminary results suggest that the serum GDNF level may not be a suitable biomarker for adult ADHD, although it may be associated with the pathophysiology of persistent inattention in adult ADHD.

Keywords: Attention deficit/hyperactivity disorder; Glial cell line-derived neurotrophic factor; Inattention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Attention Deficit Disorder with Hyperactivity / blood*
  • Biomarkers / blood
  • Brain-Derived Neurotrophic Factor / blood
  • Cognition
  • Female
  • Glial Cell Line-Derived Neurotrophic Factor / blood*
  • Humans
  • Male

Substances

  • Biomarkers
  • Brain-Derived Neurotrophic Factor
  • GDNF protein, human
  • Glial Cell Line-Derived Neurotrophic Factor